MedPath

Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: a randomized controlled trial

Not Applicable
Recruiting
Conditions
subarachnoid hemorrhage
Registration Number
JPRN-UMIN000014696
Lead Sponsor
Department of Neurosurgery, National Defense Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
450
Inclusion Criteria

Not provided

Exclusion Criteria

(1) severe brain edema (2) heart dysfunction (New York Heart Association Class III or IV) (3) renal insufficiency (calculated creatinine clearance rate of less than 30 mL/min), Fisher grade 4 with massive intracerebral hematoma, and rejection of randomization.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath